Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113045503A reveals a novel palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation method enhances purity and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN111662158A discloses a robust method for axial chiral biaryl and fluorenol synthesis using Pd/norbornene catalysis, offering high enantioselectivity and supply chain reliability.
Novel silver catalyst enables high-yield asymmetric synthesis for pharmaceutical intermediates with improved supply chain reliability and cost efficiency.
Patent CN115260192B reveals a metal-free NHC catalytic route for nitrogen-containing fused rings, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed oxidation process enables high-yield production. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel rare earth catalyzed method for aromatic formamide and olefin. Offers mild conditions and high purity for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for quinolinones. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering significant cost reduction in API manufacturing and scalable production.
Patent CN102863387A reveals a copper-catalyzed route for imidazolium salts, offering high yields and mild conditions for reliable ionic liquid and catalyst precursor manufacturing.
Patent CN115536605B details iridium-catalyzed oxazole synthesis enabling efficient COX-2 inhibitor production with reduced steps and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN113735778B enables efficient synthesis of 5-trifluoromethyl imidazole. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN108047125A details a low-cost synthesis route for Argatroban intermediates. Achieve high purity and scalable supply chain reliability with optimized manufacturing processes.
Novel palladium-catalyzed carbonylation method offers high efficiency and significant cost reduction for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN117164555A reveals cobalt-catalyzed route for indole carboxamides. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chain optimization.
Novel route avoids DKP impurities, offering high purity and yield for cost-effective pharmaceutical manufacturing and scalable supply chains.
Patent CN110922369B reveals a mild Cu-catalyzed route to trifluoromethyl dihydrofuran amines, offering cost reduction and scalable supply for pharmaceutical intermediates.
Novel catalytic dehydrogenation route for 2-indol-3-yl-quinolines offers high purity and scalable manufacturing for global pharmaceutical intermediates supply chains.